Gliquidone

格列喹酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGliquidone
Drug Alias Name格列唆酮gliquidonagliquidonum格列奎酮gliquidone +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSulfonylurea receptor agonists
TargetsSulfonylurea receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryGermany
Original Approved Date1975/01/01
Country/TerritoryGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBeijing Wanhui Double-Crane Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BB08
Related LinksWikipediaDrugBankKEGG